News

Recall of Oxcarbazepine (Trileptal) Tablets

American Health Packaging Announces the Voluntary Nationwide Recall of Ibuprofen Tablets, USP, 600 mg, 100 Hospital Unit Dose and Oxcarbazepine Tablets, 300 mg, 100 Hospital Unit Dose Tweet FOR IMMEDIATE RELEASE - July 18, 2014 – American Health Packaging (Columbus, OH) has voluntarily recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in [...]

Learn more
0

Department of Defense Allocates $7.5 Million for Epilepsy Research in Appropriations Bill!

CHICAGO, July 17, 2014 /PRNewswire-USNewswire/ — “CURE applauds the announcement today from the U.S. Department of Defense – allocating $7.5 million dedicated to epilepsy research – and thanks Senator Dick Durbin (D-IL) for his leadership on this issue. The incidence of epilepsy increased by an alarming 52 percent from 2006 to 2010, with approximately 8 percent of those afflicted having been [...]

Learn more
0

The Summer Stroll is Finally Here!

June 20, 2014: The 18th Annual Summer Stroll for Epilepsy is almost here! We have been astounded by all of your efforts and are so appreciative of your dedication to raising awareness and funds for those with epilepsy. You can still register up until 2:00 pm TODAY, Friday June 20. People who do not register on the [...]

Learn more
0

Epilepsy Awareness Night at Citizens Bank Park!

Mark your calendars: July 26th is Epilepsy Awareness Night with the Philadelphia Phillies! Watch our hometown heroes take on the Arizona Diamondbacks while you treat the hero in your life to a wonderful night. Plus you’ll help us create more awareness of epilepsy! What could be better? Visit www.phillies.com/epilepsyfoundation to purchase your tickets. Prices range from $17 [...]

Learn more
1

Take Action Now and Protect Access to Medications

Pennsylvania – Protect Access to Medications Exclude Epilepsy Medications from the Prescription Drug Monitoring Program   Take Action!   The Pennsylvania Senate is considering a bill, SB 1180, which would expand the state’s Prescription Drug Monitoring Program to include Schedule V drugs, including anti-epilepsy drugs (AEDs). The House considered a bill to expand the prescription drug monitoring [...]

Learn more
0

Sign the Epilepsy Research and Medical Marijuana Petition!

  The Epilepsy Foundation of America has started a petition on the White House website. We need your help!  We are calling on the President and the Drug Enforcement Administration to reschedule marijuana to a lower level under the controlled substances act.  The Foundation supports this change to benefit greater access to marijuana and its [...]

Learn more
1

Funding for Epilepsy Services Eliminated

The Epilepsy Foundations of Pennsylvania rely on state funding to provide services for you! From first aid training’s in schools and educating Emergency Responder’s to referral services, we are able to help you better because of the support from the state budget. Unfortunately epilepsy services have been cut from the next fiscal budget. This is [...]

Learn more
2

Important Safety Announcement about Onfi (Clobazam)

FDA Warns of Serious Skin Reactions and has Approved Label Change The U.S. Food and Drug Administration (FDA) is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death. We have approved changes to the Onfi drug label and the patient [...]

Learn more
2

Take Action Now in Pennsylvania

Your Voice is Needed in Pennsylvania! Protect Access to Medication in Pennsylvania! Urge your legislator to exclude epilepsy medications from the prescription drug monitoring program The Pennsylvania legislature is considering a bill, HB 1694, that would expand the state’s Prescription Drug Monitoring Program to include anti-epilepsy drugs (AEDs). Drug monitoring programs have been established in [...]

Learn more
1